Deka Bank Deutsche Girozentrale Nevro Corp Transaction History

Deka Bank Deutsche Girozentrale

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$58.04 - $66.99 $1.92 Million - $2.21 Million	-33,000 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$35.52 - $62.62 $1.17 Million - $2.07 Million	33,000 New	33,000 $2.17 Million
Q4 2018 Feb 12, 2019	SELL	$35.43 - $56.29 $1.17 Million - $1.86 Million	-33,000 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$44.22 - $75.47 $530,640 - $905,640	12,000 Added 57.14%	33,000 $0
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $940,939 - $1.2 Million	13,000 Added 162.5%	21,000 $1.66 Million
Q1 2018 May 03, 2018	SELL	$69.46 - $88.57 $798,789 - $1.02 Million	-11,500 Reduced 58.97%	8,000 $690,000
Q3 2017 Nov 06, 2017	BUY	$80.87 - $91.08 $1.58 Million - $1.78 Million	19,500	19,500 $1.63 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.